127 related articles for article (PubMed ID: 34471081)
1. Validation of the Giannella Risk Score for the Prediction of Infection by Carbapenemase-producing Enterobacteriaceae in the Pediatric Population.
Garazzino S; Balletto E; Licciardi F; Denina M; Carraro F; Contino A; Palmero C; Ugolotti E; Silvestro E; Castagnola E
Pediatr Infect Dis J; 2022 Feb; 41(2):112-116. PubMed ID: 34471081
[TBL] [Abstract][Full Text] [Related]
2. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
[TBL] [Abstract][Full Text] [Related]
3. The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study.
Giannella M; Bartoletti M; Campoli C; Rinaldi M; Coladonato S; Pascale R; Tedeschi S; Ambretti S; Cristini F; Tumietto F; Siniscalchi A; Bertuzzo V; Morelli MC; Cescon M; Pinna AD; Lewis R; Viale P
Clin Microbiol Infect; 2019 Dec; 25(12):1525-1531. PubMed ID: 31039445
[TBL] [Abstract][Full Text] [Related]
4. Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy.
Errico G; Gagliotti C; Monaco M; Masiero L; Gaibani P; Ambretti S; Landini MP; D'Arezzo S; Di Caro A; Parisi SG; Palù G; Vespasiano F; Morsillo F; Moro ML; Procaccio F; Ricci A; Grossi PA; Pantosti A; Nanni Costa A;
Clin Microbiol Infect; 2019 Feb; 25(2):203-209. PubMed ID: 29800674
[TBL] [Abstract][Full Text] [Related]
5. Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy.
Caselli D; Cesaro S; Fagioli F; Carraro F; Ziino O; Zanazzo G; Meazza C; Colombini A; Castagnola E;
Infect Dis (Lond); 2016 Feb; 48(2):152-5. PubMed ID: 26393496
[TBL] [Abstract][Full Text] [Related]
6. Intra-Abdominal Infections by Carbapenemase-Producing
Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
Surg Infect (Larchmt); 2021 Apr; 22(3):266-273. PubMed ID: 32598237
[No Abstract] [Full Text] [Related]
7. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity.
Castagnola E; Tatarelli P; Mesini A; Baldelli I; La Masa D; Biassoni R; Bandettini R
J Infect Public Health; 2019; 12(2):270-274. PubMed ID: 30477920
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
Yan L; Sun J; Xu X; Huang S
Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea.
Park JW; Lee H; Park SY; Kim TH
Antimicrob Resist Infect Control; 2019; 8():48. PubMed ID: 30873279
[TBL] [Abstract][Full Text] [Related]
10. Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
Legeay C; Thépot-Seegers V; Pailhoriès H; Hilliquin D; Zahar JR
J Hosp Infect; 2018 Aug; 99(4):390-395. PubMed ID: 29438727
[TBL] [Abstract][Full Text] [Related]
11. A Novel Risk Factor Associated With Colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in Addition to Antimicrobial Treatment.
Cheng VC; Chen JH; So SY; Wong SC; Chau PH; Wong LM; Ching RH; Ng MM; Lee WM; Hung IF; Ho PL; Yuen KY
Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1418-1425. PubMed ID: 27619653
[TBL] [Abstract][Full Text] [Related]
12. Infections by carbapenemase-producing enterobacteriaceae in a department of urology. A new challenge.
Justo-Quintas J; Medina-Polo J; Gil-Moradillo J; Jaén-Herreros F; Lara-Isla A; Tejido-Sánchez Á
Actas Urol Esp (Engl Ed); 2018 Apr; 42(3):170-175. PubMed ID: 29157781
[TBL] [Abstract][Full Text] [Related]
13. Carbapenemase-producing Enterobacteriaceae digestive carriage at hospital readmission and the role of antibiotic exposure.
Evain S; Bourigault C; Juvin ME; Corvec S; Lepelletier D
J Hosp Infect; 2019 May; 102(1):25-30. PubMed ID: 30769146
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and treatment of IMP-type carbapenemase-producing Enterobacteriaceae bacteremia: Case series and literature review.
Soneda K; Uda K; Araki K; Murakoshi T; Yuza Y; Saito O; Kinoshita K; Higuchi H; Horikoshi Y
J Infect Chemother; 2023 Jan; 29(1):26-32. PubMed ID: 36100144
[TBL] [Abstract][Full Text] [Related]
15. Carbapenemase-producing Enterobacteriaceae in Mexico: report of seven non-clonal cases in a pediatric hospital.
Aquino-Andrade A; Merida-Vieyra J; Arias de la Garza E; Arzate-Barbosa P; De Colsa Ranero A
BMC Microbiol; 2018 Apr; 18(1):38. PubMed ID: 29673319
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-resistant
Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
Front Public Health; 2022; 10():983174. PubMed ID: 36091556
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017.
Iacchini S; Sabbatucci M; Gagliotti C; Rossolini GM; Moro ML; Iannazzo S; D'Ancona F; Pezzotti P; Pantosti A
Euro Surveill; 2019 Jan; 24(5):. PubMed ID: 30722813
[TBL] [Abstract][Full Text] [Related]
18. Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
Hayakawa K; Nakano R; Hase R; Shimatani M; Kato H; Hasumi J; Doi A; Sekiya N; Nei T; Okinaka K; Kasahara K; Kurai H; Nagashima M; Miyoshi-Akiyama T; Kakuta R; Yano H; Ohmagari N
J Antimicrob Chemother; 2020 Mar; 75(3):697-708. PubMed ID: 31789374
[TBL] [Abstract][Full Text] [Related]
19. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries.
Villegas MV; Pallares CJ; Escandón-Vargas K; Hernández-Gómez C; Correa A; Álvarez C; Rosso F; Matta L; Luna C; Zurita J; Mejía-Villatoro C; Rodríguez-Noriega E; Seas C; Cortesía M; Guzmán-Suárez A; Guzmán-Blanco M
PLoS One; 2016; 11(4):e0154092. PubMed ID: 27104910
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
Nabarro LEB; Shankar C; Pragasam AK; Mathew G; Jeyaseelan V; Veeraraghavan B; Verghese VP
Pediatr Infect Dis J; 2017 Jun; 36(6):e161-e166. PubMed ID: 28005691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
